Healthcare partner jumps to Flexpoint Ford from Avista

Flexpoint Ford, which in the last two decades has raised more than $7 billion in commitments earmarked for healthcare and financial services, has hired Joshua Tamaroff as a managing director on its healthcare team, Private Equity Carer News has learned.

Tamaroff most recently served as a partner at New York City-based healthcare specialist Avista Capital Partners, where he  spent about 13 years and which earlier this year closed its sixth fund at $1.5 billion.

In his new role at Chicago and New York City-based Flexpoint Ford, Tamaroff will identify, evaluate and execute healthcare investments, his team bio states. He is among about 68 team members listed on the company Web site. We were unable to interview executives at Flexpoint Ford or Avista Capital Partners by press time.

The Trend: Senior partners with healthcare deal experience are evidently in high demand. Also this week, New York City-based buyout giant Clayton, Dubilier & Rice, on the heels of closing its twelfth flagship fund at about $23.6 billion, announced it had hired Adam Karol as a healthcare partner. Karol previously served as a managing director at Silver Lake.

The Bona Fides: Tamaroff served as a director for several Avista Capital Partners portfolio companies. They include pharmaceutical company Cosette Pharmaceuticals, manufacturer GCM Holding Corporation, antibody specialist OmiAb, diagnostic imaging firm Probo Medical, and dental prosthetics firm Terrats Medical. Before joining Avista Capital Partners in 2009 Tamaroff worked as an analyst for investment banks Lehman Brothers and Barclays Capital. He left Avista Capital Partners in 2012 to study for an MBA at The Wharton School, then returned in 2014 as a vice president. Tamaroff’s promotion to partner was included in a 2021 company announcement.

Flexpoint Ford: Founded almost 20 years ago, Flexpoint Ford managed about $8 billion in discretionary assets at the end of 2023, a narrative brochure noted. The firm was raising money toward a target of $2.5 billion for its fifth fund, according to a 2022 regulatory filing for Flexpoint Fund V-A LP.

Avista Capital Partners: Avista Capital Partners, founded in 2005, has invested more than $8 billion in some 45 healthcare businesses operating in medical devices, pharmaceuticals, healthcare technology and other healthcare sub-sectors. The firm managed about $4.8 billion in discretionary assets at the end of 2023, according to a narrative brochure. Tamaroff was among about six partners at Avista Capital Partners. The firm lists about 36 people in total on its team page.